HCW Biologics (HCWB) Interest Expenses (2020 - 2025)

HCW Biologics (HCWB) has 6 years of Interest Expenses data on file, last reported at $212128.0 in Q4 2025.

• Quarterly Interest Expenses rose 20.62% year-over-year to $212128.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $823734.0 (up 45.9% YoY) and the FY2025 annual result came in at $27.4 million, up 4.56% from the prior year.
• Interest Expenses grew to $212128.0 in Q4 2025, from $127070.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.8 million in Q2 2023 to a low of -$1423.0 in Q4 2023.
• A 5-year average of $373755.5 and a median of $171322.0 in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses sank 101.51% — and 2024, when it soared 12458.54%.
• Tracing HCWB's Interest Expenses over 5 years: stood at $1.1 million in 2021, then tumbled by 91.6% to $94476.0 in 2022, then sank by 101.51% to -$1423.0 in 2023, then soared by 12458.54% to $175862.0 in 2024, then grew by 20.62% to $212128.0 in 2025.
• The last three Interest Expenses figures came in at $212128.0 (Q4 2025), $127070.0 (Q3 2025), and $228714.0 (Q2 2025), per Business Quant data.